News for Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. (NASDAQ:SANA) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has assumed coverage on Sana Biotechnology, Inc.

We have all heard the old saying, “A penny makes a dime,” highlighting the idea that every little effort counts toward a bigger goal.

Morgan Stanley has announced a new analyst rating for Sana Biotechnology (SANA) as of July 3, 2025. The prominent financial services company has rated SANA as "

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 10 best healthcare penny stocks to buy according to analysts. The company’s stock surged 12.1% on June 23 after it announced positive six-month follow-up results from an investigator-sponsored, first-in-human study of its type 1 diabetes treatment. The therapy in focus is UP421, which consists of cadaver-sourced pancreatic […]

Sana Biotechnology (SANA) has released promising six-month follow-up data from an innovative study involving their engineered islet cell therapy, UP421, for typ

Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Mon

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Monday. Shares of Tesla, Inc. TSLA rose sharply during Monday's session amid the ...

**media[662163]**

Sana Biotechnology (SANA) to present updated six-month clinical results at the 85th Annual ADA Scientific Sessions. UP421, a hypoimmune-modified islet c

**media[649900]**

PR NewswireNEW YORK, May 19, 2025 NEW YORK, May 19, 2025 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Sana Biotechnolog

PR NewswireLOS ANGELES, May 19, 2025 LOS ANGELES, May 19, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (”œSana” or

NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn...

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Sana Biot

PR NewswireNEW YORK, May 17, 2025 NEW YORK, May 17, 2025 /PRNewswire/ --

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. ( SANA). Shareholders w

PR NewswireNEW YORK, May 15, 2025 NEW YORK, May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnolo

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (”œSana” or